Nonoptimal Microbial Response to Antibiotics Underlies Suppressive Drug Interactions

Cell

Volumn 139, Issue 4, 2009, Pages 707-718

  Bollenbach, Tobias ^a   Quan, Selwyn ^c   Chait, Remy ^a   Kishony, Roy ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

MICROBIO; SYSBIO

Indexed keywords

CIPROFLOXACIN; NALIDIXIC ACID; NITROFURANTOIN; SPIRAMYCIN; TETRACYCLINE; TRIMETHOPRIM;

ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CELL GROWTH; CELL SIZE; CELL SURVIVAL; CHROMOSOME REPLICATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESPONSE; ESCHERICHIA COLI; GENE CONTROL; GENE EXPRESSION REGULATION; MATHEMATICAL MODEL; MINIMUM INHIBITORY CONCENTRATION; MITOSIS INHIBITION; NONHUMAN; OPERON; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; UPREGULATION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ANTI-INFECTIVE AGENTS; DNA; DRUG INTERACTIONS; ESCHERICHIA COLI; NUCLEIC ACID SYNTHESIS INHIBITORS; PROTEIN BIOSYNTHESIS; RIBOSOMES;

EID: 70350769418     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2009.10.025     Document Type: Article

References (76)

1. Asai T., Condon C., Voulgaris J., Zaporojets D., Shen B., Al-Omar M., Squires C., and Squires C.L. Construction and initial characterization of Escherichia coli strains with few or no intact chromosomal rRNA operons. J. Bacteriol. 181 (1999) 3803-3809
2. Balaban N.Q., Merrin J., Chait R., Kowalik L., and Leibler S. Bacterial persistence as a phenotypic switch. Science 305 (2004) 1622-1625
3. Barker M.M., Gaal T., and Gourse R.L. Mechanism of regulation of transcription initiation by ppGpp. II. Models for positive control based on properties of RNAP mutants and competition for RNAP. J. Mol. Biol. 305 (2001) 689-702
4. Bartlett M.S., and Gourse R.L. Growth rate-dependent control of the rrnB P1 core promoter in Escherichia coli. J. Bacteriol. 176 (1994) 5560-5564
5. Bliss C.I. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26 (1939) 585-615
6. Brazas M.D., and Hancock R.E. Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. Drug Discov. Today 10 (2005) 1245-1252
7. Bremer H., and Dennis P.P. Modulation of Chemical Composition and Other Parameters of the Cell by Growth Rate. In: Neidhardt F.C. (Ed). Echerichia coli and Salmonella (1996), ASM Press, Washington, D.C. 1553-1569
8. Cashel M., Gentry D.R., Hernandez V.J., and Vinella D. The Stringent Response. In: Neidhardt F.C. (Ed). Echerichia coli and Salmonella (1996), ASM Press, Washington, D.C. 1458-1496
9. Chait R., Craney A., and Kishony R. Antibiotic interactions that select against resistance. Nature 446 (2007) 668-671
10. Condon C., French S., Squires C., and Squires C.L. Depletion of functional ribosomal RNA operons in Escherichia coli causes increased expression of the remaining intact copies. EMBO J. 12 (1993) 4305-4315
11. Condon C., Liveris D., Squires C., Schwartz I., and Squires C.L. rRNA operon multiplicity in Escherichia coli and the physiological implications of rrn inactivation. J. Bacteriol. 177 (1995) 4152-4156
12. Davies J., Spiegelman G.B., and Yim G. The world of subinhibitory antibiotic concentrations. Curr. Opin. Microbiol. 9 (2006) 445-453
13. Dekel E., and Alon U. Optimality and evolutionary tuning of the expression level of a protein. Nature 436 (2005) 588-592
14. Dennis P.P., Ehrenberg M., and Bremer H. Control of rRNA synthesis in Escherichia coli: a systems biology approach. Microbiol. Mol. Biol. Rev. 68 (2004) 639-668
15. Donachie W.D. Relationship between cell size and time of initiation of DNA replication. Nature 219 (1968) 1077-1079
16. Donachie W.D., and Blakely G.W. Coupling the initiation of chromosome replication to cell size in Escherichia coli. Curr. Opin. Microbiol. 6 (2003) 146-150
17. Drlica K., Malik M., Kerns R.J., and Zhao X. Quinolone-mediated bacterial death. Antimicrob. Agents Chemother. 52 (2008) 385-392
18. Dwyer D.J., Kohanski M.A., Hayete B., and Collins J.J. Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 3 (2007) 91
19. Fajardo A., and Martinez J.L. Antibiotics as signals that trigger specific bacterial responses. Curr. Opin. Microbiol. 11 (2008) 161-167
20. Fraenkel D.G., and Neidhardt F.C. Use of chloramphenicol to study control of RNA synthesis in bacteria. Biochim. Biophys. Acta 53 (1961) 96-110
21. Friedman N., Vardi S., Ronen M., Alon U., and Stavans J. Precise temporal modulation in the response of the SOS DNA repair network in individual bacteria. PLoS Biol. 3 (2005) e238
22. Gaal T., Bartlett M.S., Ross W., Turnbough Jr. C.L., and Gourse R.L. Transcription regulation by initiating NTP concentration: rRNA synthesis in bacteria. Science 278 (1997) 2092-2097
23. Gaal T., and Gourse R.L. Guanosine 3′-diphosphate 5′-diphosphate is not required for growth rate-dependent control of rRNA synthesis in Escherichia coli. Proc. Natl. Acad. Sci. USA 87 (1990) 5533-5537
24. Georgopapadakou N.H., and Bertasso A. Effects of quinolones on nucleoid segregation in Escherichia coli. Antimicrob. Agents Chemother. 35 (1991) 2645-2648
25. Goh E.B., Yim G., Tsui W., McClure J., Surette M.G., and Davies J. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc. Natl. Acad. Sci. USA 99 (2002) 17025-17030
26. Gralla J.D. Escherichia coli ribosomal RNA transcription: regulatory roles for ppGpp, NTPs, architectural proteins and a polymerase-binding protein. Mol. Microbiol. 55 (2005) 973-977
27. Guan L., and Burnham J.C. Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli: effect on morphology and haemolysin activity. J. Antimicrob. Chemother. 29 (1992) 529-538
28. Guido N.J., Lee P., Wang X., Elston T.C., and Collins J.J. A pathway and genetic factors contributing to elevated gene expression noise in stationary phase. Biophys. J. 93 (2007) L55-L57
29. Hegreness M., Shoresh N., Damian D., Hartl D., and Kishony R. Accelerated evolution of resistance in multidrug environments. Proc. Natl. Acad. Sci. USA 105 (2008) 13977-13981
30. Hoffman L.R., D'Argenio D.A., MacCoss M.J., Zhang Z., Jones R.A., and Miller S.I. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436 (2005) 1171-1175
31. Huisman O., and D'Ari R. An inducible DNA replication-cell division coupling mechanism in E. coli. Nature 290 (1981) 797-799
32. Ibarra R.U., Edwards J.S., and Palsson B.O. Escherichia coli K-12 undergoes adaptive evolution to achieve in silico predicted optimal growth. Nature 420 (2002) 186-189
33. Izutsu K., Wada A., and Wada C. Expression of ribosome modulation factor (RMF) in Escherichia coli requires ppGpp. Genes Cells 6 (2001) 665-676
34. Kaplan S., Bren A., Zaslaver A., Dekel E., and Alon U. Diverse two-dimensional input functions control bacterial sugar genes. Mol. Cell 29 (2008) 786-792
35. Keener J., and Nomura M. Regulation of Ribosome Synthesis. In: Neidhardt F.C. (Ed). Escherichia Coli and Salmonella (1996), ASM Press, Washington, D.C. 1417-1431
36. Keith C.T., Borisy A.A., and Stockwell B.R. Multicomponent therapeutics for networked systems. Nat. Rev. Drug Discov. 4 (2005) 71-78
37. Khan S.R., and Yamazaki H. Trimethoprim-induced accumulation of guanosine tetraphosphate (ppGpp) in Escherichia coli. Biochem. Biophys. Res. Commun. 48 (1972) 169-174
38. Kohanski M.A., Dwyer D.J., Hayete B., Lawrence C.A., and Collins J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130 (2007) 797-810
39. Kohanski M.A., Dwyer D.J., Wierzbowski J., Cottarel G., and Collins J.J. Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135 (2008) 679-690
40. Kolodkin-Gal I., Sat B., Keshet A., and Engelberg-Kulka H. The communication factor EDF and the toxin-antitoxin module mazEF determine the mode of action of antibiotics. PLoS Biol. 6 (2008) e319
41. Kurland C.G., and Maaløe O. Regulation of ribosomal and transfer RNA synthesis. J. Mol. Biol. 4 (1962) 193-210
42. Kussell E., and Leibler S. Phenotypic diversity, population growth, and information in fluctuating environments. Science 309 (2005) 2075-2078
43. Lehár J., Krueger A., Zimmermann G., and Borisy A. High-order combination effects and biological robustness. Mol. Syst. Biol. 4 (2008) 215
44. Lehár J., Zimmermann G.R., Krueger A.S., Molnar R.A., Ledell J.T., Heilbut A.M., Short III G.F., Giusti L.C., Nolan G.P., Magid O.A., et al. Chemical combination effects predict connectivity in biological systems. Mol. Syst. Biol. 3 (2007) 80
45. Levy S., Ihmels J., Carmi M., Weinberger A., Friedlander G., and Barkai N. Strategy of transcription regulation in the budding yeast. PLoS ONE 2 (2007) e250
46. Liebermeister W., Klipp E., Schuster S., and Heinrich R. A theory of optimal differential gene expression. Biosystems 76 (2004) 261-278
47. Linares J.F., Gustafsson I., Baquero F., and Martinez J.L. Antibiotics as intermicrobial signaling agents instead of weapons. Proc. Natl. Acad. Sci. USA 103 (2006) 19484-19489
48. Loewe S. Die quantitativen Probleme der Pharmakologie. Ergeb. Physiol. 27 (1928) 47-187
49. Loewe S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3 (1953) 285-290
50. Mason D.J., Power E.G., Talsania H., Phillips I., and Gant V.A. Antibacterial action of ciprofloxacin. Antimicrob. Agents Chemother. 39 (1995) 2752-2758
51. Mesak L.R., Miao V., and Davies J. Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus. Antimicrob. Agents Chemother. 52 (2008) 3394-3397
52. Michel B. After 30 years of study, the bacterial SOS response still surprises us. PLoS Biol. 3 (2005) e255
53. Michel J.B., Yeh P.J., Chait R., Moellering Jr. R.C., and Kishony R. Drug interactions modulate the potential for evolution of resistance. Proc. Natl. Acad. Sci. USA 105 (2008) 14918-14923
54. Mitchell A., Romano G.H., Groisman B., Yona A., Dekel E., Kupiec M., Dahan O., and Pilpel Y. Adaptive prediction of environmental changes by microorganisms. Nature 460 (2009) 220-224
55. Moss T. At the crossroads of growth control; making ribosomal RNA. Curr. Opin. Genet. Dev. 14 (2004) 210-217
56. Paul B.J., Ross W., Gaal T., and Gourse R.L. rRNA transcription in Escherichia coli. Annu. Rev. Genet. 38 (2004) 749-770
57. Pearl S., Gabay C., Kishony R., Oppenheim A., and Balaban N.Q. Nongenetic individuality in the host-phage interaction. PLoS Biol. 6 (2008) e120
58. Piddock L.J., Walters R.N., and Diver J.M. Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli. Antimicrob. Agents Chemother. 34 (1990) 2331-2336
59. Pillai S.K., Moellering R.C., and Eliopoulos G.M. Antimicrobial combinations. In: Lorian V. (Ed). Antibiotics in Laboratory Medicine (2005), Lippincott Williams and Wilkins, Philadelphia 365-440
60. Poole K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56 (2005) 20-51
61. Radman M. SOS repair hypothesis: phenomenology of an inducible DNA repair which is accompanied by mutagenesis. Basic Life Sci. 5A (1975) 355-367
62. Schneider D.A., Gaal T., and Gourse R.L. NTP-sensing by rRNA promoters in Escherichia coli is direct. Proc. Natl. Acad. Sci. USA 99 (2002) 8602-8607
63. Schneider D.A., and Gourse R.L. Relationship between growth rate and ATP concentration in Escherichia coli: a bioassay for available cellular ATP. J. Biol. Chem. 279 (2004) 8262-8268
64. Shaw K.J., Miller N., Liu X., Lerner D., Wan J., Bittner A., and Morrow B.J. Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents. J. Mol. Microbiol. Biotechnol. 5 (2003) 105-122
65. Smith R.J., and Midgley J.E. The effect of trimethoprim on macromolecular synthesis in Escherichia coli. Regulation of ribonucleic acid synthesis by 'Magic Spot' nucleotides. Biochem. J. 136 (1973) 249-257
66. Stevenson B.S., and Schmidt T.M. Life history implications of rRNA gene copy number in Escherichia coli. Appl. Environ. Microbiol. 70 (2004) 6670-6677
67. Tagkopoulos I., Liu Y.C., and Tavazoie S. Predictive behavior within microbial genetic networks. Science 320 (2008) 1313-1317
68. Tippin B., Pham P., and Goodman M.F. Error-prone replication for better or worse. Trends Microbiol. 12 (2004) 288-295
69. Tsui W.H., Yim G., Wang H.H., McClure J.E., Surette M.G., and Davies J. Dual effects of MLS antibiotics: transcriptional modulation and interactions on the ribosome. Chem. Biol. 11 (2004) 1307-1316
70. Walker G.C. The SOS Response of Escherichia coli. In: Neidhardt F.C. (Ed). Echerichia coli and Salmonella (1996), ASM Press, Washington, D.C. 1400-1416
71. Xiao H., Kalman M., Ikehara K., Zemel S., Glaser G., and Cashel M. Residual guanosine 3′,5′-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations. J. Biol. Chem. 266 (1991) 5980-5990
72. Yeh P., Tschumi A.I., and Kishony R. Functional classification of drugs by properties of their pairwise interactions. Nat. Genet. 38 (2006) 489-494
73. Yim G., Wang H.H., and Davies J. The truth about antibiotics. Int. J. Med. Microbiol. 296 (2006) 163-170
74. Yim G., Wang H.H., and Davies J. Antibiotics as signalling molecules. Philos. Trans. R. Soc. Lond. B Biol. Sci. 362 (2007) 1195-1200
75. Zaslaver A., Bren A., Ronen M., Itzkovitz S., Kikoin I., Shavit S., Liebermeister W., Surette M.G., and Alon U. A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat. Methods 3 (2006) 623-628
76. Zaslaver A., Mayo A.E., Rosenberg R., Bashkin P., Sberro H., Tsalyuk M., Surette M.G., and Alon U. Just-in-time transcription program in metabolic pathways. Nat. Genet. 36 (2004) 486-491